Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
RMD Open|January 10, 2024
Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohortMoritz Scheidegger, Marouane Boubaya, Alexandru Garaiman, et al.Oxidative Medicine and Cellular Longevity|July 26, 2012
Detailed analysis of apoptosis and delayed luminescence of human leukemia Jurkat T cells after proton irradiation and treatments with oxidant agents and flavonoidsIrina Baran, Constanta Ganea, Simona Privitera, et al.Swiss Medical Weekly|April 5, 2024
Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohortKevin Windirsch, Suzana Jordan, Mike Oliver Becker, et al.Rheumatology (Oxford, England)|August 14, 2025
A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC ScoreCosimo Bruni, Lorenzo Tofani, Håvard Fretheim, et al.Rheumatology (Oxford, England)|July 29, 2022
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC modelAlexandru Garaiman, Klaus Steigmiller, Catherine Gebhard, et al.RMD Open|November 28, 2024
Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosisRucsandra Dobrota, Alexandru Garaiman, Kim Fligelstone, et al.Annals of the Rheumatic Diseases|November 26, 2021
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaireMike O Becker, Rucsandra Dobrota, Alexandru Garaiman, et al.Annals of the Rheumatic Diseases|February 2, 2025
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR databaseQingran Yan, Cosimo Bruni, Alexandru Garaiman, et al.Pageof 2